Abstract:Objective: To investigate the difference in gene expression of radiation-sensitive and radiation-resistant nasopharyngeal carcinoma(NPC) tissues. Methods: Genetic fingerprinting was utilized to predict the radiation sensitivity of NPC. Nineteen NPC samples were assessed by BioStarH-141s(2004) cDNA gene expression profiling, with each chip containing 14112 spots of full length human genes. The 19 biopsies were classified into two groups: 8 samples were radiation-sensitive cases, whereas the other 11 were radiation-resistant cases. Methods of biostatistics and bioinformatics were used to analyze the differentially expressed genes. Results: Comparing gene expression profiles of the radiation-sensitive group with the resistant group, there were 164 differentially expressed genes(P<0.01), and 17 differentially expressed genes(P<0.001). In a comparison with nasopharyngeal chronic inflammatory tissue, 267 genes were found to be expressed differentially more than two-fold in at least 70% of the radiation-sensitive samples, and 106 similarly expressed genes were found in at least 70% of the radiation-resistant cases. Some of the genes were related to radiation sensitivity such as PRKD and DCK, whereas others had no reported connection with radiation sensitivity including SIRT1, RABAC1, PPP1CC and ZNF638. These genes were mostly related to cell cycle, checkpoint of S and M phases, cell death and development, or DNA or RNA binding. Also, some genes, including CUTA, ZNF148, Sep15, TMTC3 and TOP1, were recently discovered and their functions remain unknown. Using a group of 98 genes expressed differentially between the resistant and sensitive groups(P<0.01), 19 specimens could be classified into two groups: radiation sensitive and radiation resistant. Eighteen of them were consistent with their clinical outcome. Testified by LOOCV, the cluster accuracy was 100%. Conclusion: Gene expression of radiation sensitive NPC tissue is significantly different from that of radiation resistant tumors. Gene expression differs more in the radiation sensitive group than in the resistant group. With a group of differentially expressed genes, genetic fingerprinting can be utilized to predict sensitivity of NPC to radiation.

Radiosensitivity-Related Genes and Clinical Characteristics of Nasopharyngeal Carcinoma

Identification of Prognostic Biomarkers for Response to Radiotherapy by DNA Microarray in Nasopharyngeal Carcinoma Patients

Key radioresistance regulation models and marker genes identified by integrated transcriptome analysis in nasopharyngeal carcinoma

Comprehensive analysis of key genes and microRNAs in radioresistant nasopharyngeal carcinoma

RNA-Seq Analysis of Peripheral Blood Mononuclear Cells Reveals Unique Transcriptional Signatures Associated with Radiotherapy Response of Nasopharyngeal Carcinoma and Prognosis of Head and Neck Cancer

Narrow band imaging-based radiogenomics for predicting radiosensitivity in nasopharyngeal carcinoma

Radio-Susceptibility of Nasopharyngeal Carcinoma: Focus on Epstein- Barr Virus, MicroRNAs, Long Non-Coding RNAs and Circular RNAs

Identification of Mutations in Cancer Predisposition Genes in Radiosensitive and Radioresistant Patients with Nasopharyngeal Carcinoma

Irradiation-induced dynamic changes of gene signatures reveal gain of metastatic ability in nasopharyngeal carcinoma.

Genome-Wide Analyses of Radioresistance-Associated Mirna Expression Profile in Nasopharyngeal Carcinoma Using Next Generation Deep Sequencing

Predicting Radiation Sensitivity of Nasopharyngeal Carcinoma Using Genetic Fingerprinting

Integrated Analysis of Differential Mirna and Mrna Expression Profiles in Human Radioresistant and Radiosensitive Nasopharyngeal Carcinoma Cells.

Genetic Variations in Radiation and Chemotherapy Drug Action Pathways Predict Clinical Outcomes in Locoregionally Advanced Nasopharyngeal Carcinoma

Ott_a_207810 5661..5677

Serum proteomics identify potential biomarkers for nasopharyngeal carcinoma sensitivity to radiotherapy.

A two-stage genome-wide association study identifies novel germline genetic variations in CACNA2D3 associated with radiotherapy response in nasopharyngeal carcinoma

Prognostic Analysis of Patients with Locally Advanced Nasopharyngeal Carcinoma Following Intensity Modulated Radiation Therapy.

Immune dysregulation underpins radioresistance in nasopharyngeal carcinoma (NPC).

Impact of Polymorphisms in Angiogenesis-Related Genes on Clinical Outcomes of Radiotherapy in Patients with Nasopharyngeal Carcinoma.

Establishment of Radioresistant Human Nasopharyngeal Carcinoma Cells and the Differential Gene Expression by Cdna Microarray Analysis

The impacts of single nucleotide polymorphisms in genes of cell cycle and NF-kB pathways on the efficacy and acute toxicities of radiotherapy in patients with nasopharyngeal carcinoma.